FIELD: medicine. SUBSTANCE: method involves producing blood plasma rich and poor in thrombocytes. Plasma poor in blood platelets is used as substratum for determining thrombocyte activity. Plasma rich in blood platelets is used as material under study. Activated recalcification time of plasma poor in blood platelets is determined without any additives used. Then the activated recalcification time of the same plasma is determined with equal volume of plasma rich in blood platelets previously added. The difference between the first and the second analysis is used to determine the value of coagulation activity of blood platelets. EFFECT: enhanced accuracy of the method.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIFFERENTIATED EVALUATION OF HEMOSTASIS IN PREMATURE NEONATALS | 2002 |
|
RU2216745C2 |
| METHOD FOR DETERMINING LUPUS ERYTHEMATOSUS ANTICOAGULANT AVAILABILITY | 1999 |
|
RU2181203C2 |
| DETERMINING OF CIRCULATING THROMBIN IN COMPLEMENT ACTIVATION TEST | 2019 |
|
RU2709341C1 |
| METHOD OF DETERMINING ANTIHEPARIN ACTIVITY OF THROMBOCYTES | 0 |
|
SU1767420A1 |
| METHOD OF DETERMINING THROMBIN COMPLEMENTARITY SYSTEM ACTIVATION PATHWAY | 2019 |
|
RU2717946C1 |
| METHOD OF DETERMINING ACTIVITY OF ANTITHROMBIN III IN BLOOD PLASMA | 0 |
|
SU1464090A1 |
| METHOD OF DETERMINING ACTIVITY OF ANTITHROMBIN-III IN BLOOD PLASMA | 0 |
|
SU1508169A1 |
| METHOD FOR DIAGNOSING ANTIPHOSPHOLIPID SYNDROME | 1995 |
|
RU2104550C1 |
| METHOD FOR DETERMINATION OF ACTIVATED FACTOR VII IN BLOOD PLASMA | 1991 |
|
RU2034298C1 |
| METHOD OF DETERMINING HEPARIN-COFACTOR ACTIVITY OF ANTITHROMBIN III BLOOD PLASMA CONTAINING HEPARIN | 0 |
|
SU1461462A1 |
